Always up-to-date

Newsroom

Spotlight

Media

BCI generates media interest, we have the news.

Badische Zeitung
April 2026
Für Schlaganfallpatienten: Unternehmen Cortec nimmt Zulassungshürde
mobihealthnews
April 2026
CorTec becomes first German BCI company to get FDA Breakthrough designation
VC-Magazine
April 2026
FDA has granted CorTecs‘ Breakthrough Device Designation
Mass Device
April 2026
CorTec wins FDA breakthrough nod for BCI system
Medical Product Outsourcing
April 2026
CorTec Gets FDA Breakthrough Nod for Brain Interchange BCI System
Medical Device Network
April 2026
CorTec gains FDA breakthrough designation for stroke rehabilitation BCI
BioWorld
March 2026
Med-tech outlook 2026: exits, financings, headwinds
Breisgau Live - German Article
February 2026
wvib-Konjunkturumfrage: Aufschwung lässt auf sich warten

Press Releases & News

BCI generates media interest, we have the news.

CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System

In February 2026, a second patient at Harborview Medical Center in Seattle successfully received the Brain Interchange™ implant as part of an NIH-funded, FDA-approved trial led by researchers from the University of Washington and UCLA. Building on encouraging results from the first participant, the study continues to advance CorTec’s clinical program for stroke recovery.

„This therapy literally brought me back from the dead"

In December 2025, the University of Washington shared the story of Matt Kidd, a stroke patient who regained motor function as part of a clinical trial using a brain implant developed in collaboration with CorTec. After years of therapy with little progress, targeted electrical stimulation helped his nerve cells reconnect and within weeks he was able to perform everyday movements again.

CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany

In July 2025, CorTec achieved a historic milestone with the first-ever human implantation of a fully implantable, German-developed Brain-Computer Interface system, performed at Harborview Medical Center in Seattle. As part of an FDA-approved trial led by researchers from the University of Washington and UCLA, the study targets motor recovery in stroke patients and marks a major step forward in neurorehabilitation.

CorTec Receives FDA Approval for First-in-Human Implantation of the Brain Interchange™ System

In October 2024, CorTec received both FDA Investigational Device Exemption and IRB approval from the University of Washington, clearing the path for the first-ever human implantation of a fully implantable, German-developed Brain-Computer Interface system. The study, conducted in collaboration with researchers from the University of Washington and UCLA, targets motor recovery in stroke patients with arm paralysis.

Publications

Peer-reviewed publications with the Brain Interchange. 

Cho H, Benjaber M, Alexis Gkogkidis C, et al.,  IEEE Trans Neural Syst Rehabil Eng. 2024;32:3625-3635. 

Cho, Hanbin & J. Herron, 2023 11th International IEEE/EMBS Conference on Neural Engineering (NER), Baltimore, MD, USA, 2023, pp. 1-6.

Brain Interchange Bci Neural Interfacing System: Neural Recording And Stimulation Using Micro-Ecog And Dbs Electrodes In Sheep

Gkogkidis, C. Alexis et al. Neuromodulation, Volume 25, Issue 7, S249 – S250; PO113 / #853 

Biopotential Measurements and Electrodes.

Akinin, A., Paul, A., Wang, J., Buccino, A., Cauwenberghs, G. (2020). In: He, B. (eds) Neural Engineering. Springer, Cham. 

Casimo K, Levinson LH, Zanos S, et al., Brain Behav. 2017; 7(12):e00863. Published 2017 Nov 22. 

Closed-loop interaction with the cerebral cortex using a novel micro-ECoG-based implant: the impact of beta vs. gamma stimulation frequencies on cortico-cortical spectral responses.

Gkogkidis, C. A. et al. (2017), Brain-Computer Interfaces, 4(4), pp. 214–224.

Kohler, F. et al. (2017) Brain-Computer Interfaces, 4(3), pp. 146–154. 

Gierthmuehlen M, Wang X, Gkogkidis A, et al. J Comp Neurol. 2014;522(16):3590-3608.

Schalk, Gerwin, and Health Research, Inc. at Wadsworth Menands United States, (2016): 0014.

Custom development & manufacturing for active implantable devices. Your partner from design to regulatory-ready product.